deltatrials
Active Not Recruiting OBSERVATIONAL NCT04030338

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

Serial PSMA PET Imaging in the Assessment of Treatment Response in Patients With Progressive Prostate Cancer

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Metastatic Prostate Cancer Prostate Adenocarcinoma Prostate Cancer Prostate Cancer Metastatic Prostate Neoplasm
Interventions 18F-DCFPyL-iPSMA 68Ga-HBED-iPSMA PET/CT scan
Updated 15 times since 2019 Last updated: Aug 26, 2025 Started: Jul 19, 2019 Primary completion: Jul 31, 2026 Completion: Jul 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Metastatic Prostate Cancer and Prostate Adenocarcinoma and is currently ongoing. Memorial Sloan Kettering Cancer Center leads this study, which shows 15 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Jan 2020 · 3 months · monthly snapshot~Jan 2020 – ~Sep 2020 · 8 months · monthly snapshot~Sep 2020 – ~Dec 2020 · 3 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Sep 2022 · 9 months · monthly snapshot~Sep 2022 – ~Aug 2023 · 11 months · monthly snapshot~Aug 2023 – ~May 2024 · 9 months · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshot~Jun 2025 – ~Oct 2025 · 4 months · monthly snapshot~Oct 2025 – present · 9 months · monthly snapshot

Change History

15 versions recorded

  1. Oct 2025 — Present [monthly]

    Active Not Recruiting

  2. Jun 2025 — Oct 2025 [monthly]

    Active Not Recruiting

  3. Sep 2024 — Jun 2025 [monthly]

    Active Not Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  5. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

▶ Show 10 earlier versions

  1. May 2024 — Jun 2024 [monthly]

    Recruiting

  2. Aug 2023 — May 2024 [monthly]

    Recruiting

  3. Sep 2022 — Aug 2023 [monthly]

    Recruiting

  4. Dec 2021 — Sep 2022 [monthly]

    Recruiting

  5. Jan 2021 — Dec 2021 [monthly]

    Recruiting

  6. Dec 2020 — Jan 2021 [monthly]

    Recruiting

  7. Sep 2020 — Dec 2020 [monthly]

    Recruiting

  8. Jan 2020 — Sep 2020 [monthly]

    Recruiting

  9. Oct 2019 — Jan 2020 [monthly]

    Recruiting

  10. Aug 2019 — Oct 2019 [monthly]

    Recruiting

    First recorded

Jul 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Memorial Sloan Kettering Cancer Center
  • Progenics Pharmaceuticals, Inc.
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations